The role of local and systemic control methods in the treatment of oligometastatic breast cancer, taking into account biological subtypes (literature review)
Authors:
- T. Yu. SemiglazovaTST. Yu. Semiglazova
- O. I. PonasenkoOPO. I. Ponasenko
- V. A. LyaschenkoVLV. A. Lyaschenko
- Sh. R. AbdullaevaSASh. R. Abdullaeva
- L. V. FilatovaLFL. V. Filatova
- Zh. V. BryantsevaZBZh. V. Bryantseva
- R. M. PaltuevRPR. M. Paltuev
- V. V. SemiglazovVSV. V. Semiglazov
- П. В. КриворотькоПКП. В. Криворотько
- S. N. NovikovSNS. N. Novikov
Open Access
- 8 November 2024
- journal article
- Published by Publishing House ABV Press in Tumors of female reproductive system
- Vol. 20 (3) , 31-43
Abstract
Combined methods of treatment of oligometastatic breast cancer (OMBC) based on systemic drug treatment and local treatment methods - stereotactic radiation therapy (SRT) or surgical treatment - are not included in current clinical guidelines. The European Society of Medical Oncology (ESMO) recommends the use of local control methods for patients with breast cancer without taking into account the biological subtype of the tumor. This review presents a modern understanding of the oligometastatic biological subtype based on data from clinical studies on this topic, which could contribute to decision-making in real clinical practice.The aim of the review is analysis of the effectiveness of combined treatment methods: systemic drug therapy and local treatment methods (SRT) or surgical treatment of breast cancer of various molecular genetic subtypes.To assess the clinical effectiveness of various approaches to the treatment of breast cancer, depending on the biological subtype, a search was conducted for scientific publications in the Medline bibliographic database. Prospective and retrospective studies demonstrate an increase in the effectiveness of treatment through a combination of systemic therapy and local control methods (surgical treatment or SRT) OMBC depending on the biological subtypes. In hormonepositive breast cancer with bone damage, SRT is most preferable, whereas in visceral oligometastases, surgical treatment is recommended. For immunocompetent tumors of triple-negative and HER2-positive biological subtypes of breast cancer, surgical treatment of OMBC is not recommended, except in cases where the positive status of HER2 is combined with a high level of expression of hormonal receptors or metastatic bone damage.The results of current prospective studies focusing on certain biological subtypes of breast cancer will help further determine the role of this strategy in the treatment of this cohort of patients. Understanding the characteristics of the tumor process in breast cancer will allow you to personalize the treatment of patients with this disease.Keywords
This publication has 21 references indexed in Scilit:
- Integrating radiation therapy with targeted treatments for breast cancer: From bench to bedsideCancer Treatment Reviews, 2022
- Stereotactic ablative body radiotherapy (SABR) for bone only oligometastatic breast cancer: A prospective clinical trialThe Breast, 2020
- Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendationThe Lancet Oncology, 2020
- Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trialRadiotherapy and Oncology, 2018
- Systematic review of early and long-term outcome of liver resection for metastatic breast cancer: Is there a survival benefit?The Breast, 2017
- Prolonged Overall Survival After Pulmonary Metastasectomy in Patients With Breast CancerThe Annals of Thoracic Surgery, 2013
- Oligometastases Treated With Stereotactic Body Radiotherapy: Long-Term Follow-Up of Prospective StudyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Possible clinical cure of metastatic breast cancer: lessons from our 30-year experience with oligometastatic breast cancer patients and literature reviewBreast Cancer, 2012
- Hepatic resection for metastatic breast cancer: A systematic reviewEuropean Journal of Cancer, 2011
- Patterns of Distant Failure and Progression in Breast Cancer: Implications for the Treatment of Oligometastatic DiseaseInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011